Microcosting Analysis of Diffuse Large B-Cell Lymphoma Treatment in Malawi

PURPOSE: To describe the cost of treating diffuse large B-cell lymphoma (DLBCL) in Malawi under the following circumstances: (1) palliation only, (2) first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP), (3) salvage etoposide, ifosfamide, and cisplatin (EPIC), and (4) salvage...

Descripción completa

Detalles Bibliográficos
Autores principales: Painschab, Matthew S., Kohler, Racquel E., Kasonkanji, Edwards, Zuze, Takondwa, Kaimila, Bongani, Nyasosela, Richard, Nyirenda, Ruth, Krysiak, Robert, Gopal, Satish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690619/
https://www.ncbi.nlm.nih.gov/pubmed/31322992
http://dx.doi.org/10.1200/JGO.19.00059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690619/
https://www.ncbi.nlm.nih.gov/pubmed/31322992
http://dx.doi.org/10.1200/JGO.19.00059

Ejemplares similares